Investigating how brain cell interactions and signaling contribute to changes in Alzheimer's Disease.

Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models

NIH-funded research Scripps Research Institute, the · NIH-10540117

This study is looking at how tiny particles released by brain cells might affect the health of neurons and other brain cells in people with Alzheimer's Disease, using special lab-grown brain cells to better understand these changes.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionScripps Research Institute, the NIH-funded
Lab location1 site (La Jolla, United States)
Project IDNIH-10540117 on NIH RePORTER

What this research studies

This research focuses on understanding the role of different brain cell types and their signaling mechanisms in Alzheimer's Disease (AD). It aims to explore how extracellular vesicles (EVs), which are tiny particles released by cells, can influence the health and function of neurons, astrocytes, and microglia in the context of AD. By using advanced techniques to create human brain cells from induced pluripotent stem cells (iPSCs), the study will analyze the content of EVs and how genetic factors may affect their signaling properties. This could provide insights into the early changes in brain function associated with AD.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a genetic predisposition to Alzheimer's Disease or those showing early signs of cognitive decline.

Not a fit: Patients with non-Alzheimer's forms of dementia or cognitive impairment unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new biomarkers for early detection of Alzheimer's Disease and potential therapeutic targets.

How similar studies have performed: Previous research has shown promising results in understanding the role of extracellular vesicles in other neurological diseases, suggesting potential for success in this area as well.

Where this research is happening

La Jolla, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's DiseaseAlzheimer diseaseAlzheimer syndromeAlzheimer's disease dementiaAlzheimers disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.